Delivery Order SPE2DB22D9239-SPE2DB25FDJ11
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $27.4K by the Defense Logistics Agency's Medical Supply Chain for 3,750 units of Oncaspar 5 milliliter vials. The contract is firm fixed-price with no set-aside designation and an ultimate completion date of July 28, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 delivery order is for 4,557 units of the oncology medication Oncaspar (Pegaspargase) 3,750 unit/5 mL vial. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 3,750 units of Oncaspar 5 ml vials valued at $40,717.98. The award, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, carries a firm fixed-price structure with no small business set-aside designation, indicating the contractor competed in open federal procurement. This delivery...
- This federal contract award, valued at $43,220.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,559,233,967 units of the oncology medication Oncaspar (pegaspargase) in 5 mL vials. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,717.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on January 22, 2026. The delivery order covers 3,750 units of Oncaspar 5 milliliter vials, an oncology pharmaceutical product, with a firm fixed-price structure and an ultimate completion date of February 12, 2026. This award was issued without a set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency (DLA) awarded a $49,531.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,561,926,430 units of the oncology medication Oncaspar in 5 mL vials. This contract is not associated with a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 single-award Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $43,220.28, is a firm fixed-price delivery order for the supply of 4,556,239,764 units of the oncology drug Oncaspar (pegaspargase) in 5 ml vials. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 firm fixed-price delivery order is for the supply of 4,556,804,056 units of the oncology medication ONCASPAR (pegaspargase) in 5 mL vials. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, which allows the DLA to issue...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,930.72 delivery order is for 3,750 units of the oncology medication ONCASPAR in 5 ML vials. The award is under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which enables the DLA to issue delivery orders for a comprehensive...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $49,531.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the prescription drug Oncaspar (asparaginase pegylated) in 5 mL vials. This contract is issued under a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to place delivery...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDJ11Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,351.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Oncaspar (5 mL vials). This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, was awarded without a set-aside designation. The contract falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $500 million and valid through November 2026, which enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in Defense Logistics Agency procurement. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. Oncaspar, an oncology treatment medication, represents the type of specialized pharmaceutical product the company routinely provides through its single-award indefinite delivery vehicle, which covers an extensive portfolio spanning injections, tablets, creams, auto-injectors, and other specialty medications serving military medical supply needs across the globe.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 4/24/25 |